by jwaldner@parthenonmgmt.com | Aug 7, 2024 | News
Effective November 18, 2023, Magellan has issued an updated policy regarding the coverage of TMS. The changes include: Reduction of failed medication trials from 4 to 2 from different classes Elimination of the 3 month waiting period between sessions. To review the...
by jwaldner@parthenonmgmt.com | Aug 7, 2024 | News
Photo: Michelle Cochran, MD, DLFAPA, FCTMSS at the 2023 APA Conference in San Francisco, CA. As the CTMSS ACROSS rep for the APA Assembly, I attended the APA meeting in San Francisco this year. As part of my participation as the representative between the CTMSS and...
by jwaldner@parthenonmgmt.com | Aug 7, 2024 | News
The Clinical TMS Society recommends the following coverage for Transcranial Magnetic Stimulation for Smoking Cessation COVERAGE INDICATIONS, LIMITATIONS, AND/OR MEDICAL NECESSITY Introduction: Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment that...
by jwaldner@parthenonmgmt.com | Aug 7, 2024 | News
Article by Jordan Galerkin The Clinical TMS Society’s 11th Annual Meeting took place May 4-6, 2023, in Colorado Springs. This is the first time the Annual Meeting has been held in Colorado, thanks to the efforts of the Annual Meeting Committee and its chairman at the...
by jwaldner@parthenonmgmt.com | Aug 7, 2024 | News
The Clinical TMS Society has elected the members who will serve as the 2023-2024 Officers and Board of Directors: President, Rebecca Allen, MD, MPH VP-President-Elect, Martha Koo, MD, DFAPA, FCTMSS Secretary, Sam Huber, MD, MS Treasurer, Debbie Stultz, MD, FCTMSS...
